364 related articles for article (PubMed ID: 25421467)
1. A new nonpolar N-hydroxy imidazoline lead compound with improved activity in a murine model of late-stage Trypanosoma brucei brucei infection is not cross-resistant with diamidines.
Ríos Martínez CH; Miller F; Ganeshamoorthy K; Glacial F; Kaiser M; de Koning HP; Eze AA; Lagartera L; Herraiz T; Dardonville C
Antimicrob Agents Chemother; 2015 Feb; 59(2):890-904. PubMed ID: 25421467
[TBL] [Abstract][Full Text] [Related]
2. New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289.
Wenzler T; Boykin DW; Ismail MA; Hall JE; Tidwell RR; Brun R
Antimicrob Agents Chemother; 2009 Oct; 53(10):4185-92. PubMed ID: 19620327
[TBL] [Abstract][Full Text] [Related]
3. Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness.
Kaiser M; Bray MA; Cal M; Bourdin Trunz B; Torreele E; Brun R
Antimicrob Agents Chemother; 2011 Dec; 55(12):5602-8. PubMed ID: 21911566
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiprotozoal activity of N-alkoxy analogues of the trypanocidal lead compound 4,4'-bis(imidazolinylamino)diphenylamine with improved human blood-brain barrier permeability.
Nieto L; Mascaraque A; Miller F; Glacial F; Ríos Martínez C; Kaiser M; Brun R; Dardonville C
J Med Chem; 2011 Jan; 54(2):485-94. PubMed ID: 21175162
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis.
Nare B; Wring S; Bacchi C; Beaudet B; Bowling T; Brun R; Chen D; Ding C; Freund Y; Gaukel E; Hussain A; Jarnagin K; Jenks M; Kaiser M; Mercer L; Mejia E; Noe A; Orr M; Parham R; Plattner J; Randolph R; Rattendi D; Rewerts C; Sligar J; Yarlett N; Don R; Jacobs R
Antimicrob Agents Chemother; 2010 Oct; 54(10):4379-88. PubMed ID: 20660666
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Jones AJ; Kaiser M; Avery VM
Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
[TBL] [Abstract][Full Text] [Related]
7. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
8. Trypanocidal activity of 8-methyl-5'-{[(Z)-4-aminobut-2-enyl]-(methylamino)}adenosine (Genz-644131), an adenosylmethionine decarboxylase inhibitor.
Bacchi CJ; Barker RH; Rodriguez A; Hirth B; Rattendi D; Yarlett N; Hendrick CL; Sybertz E
Antimicrob Agents Chemother; 2009 Aug; 53(8):3269-72. PubMed ID: 19451291
[TBL] [Abstract][Full Text] [Related]
9. DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity.
Dardonville C; Barrett MP; Brun R; Kaiser M; Tanious F; Wilson WD
J Med Chem; 2006 Jun; 49(12):3748-52. PubMed ID: 16759117
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the novel diamidine compound 2,5-Bis(4-amidinophenyl)- furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration.
Mdachi RE; Thuita JK; Kagira JM; Ngotho JM; Murilla GA; Ndung'u JM; Tidwell RR; Hall JE; Brun R
Antimicrob Agents Chemother; 2009 Mar; 53(3):953-7. PubMed ID: 19064893
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
Dauchy FA; Bonhivers M; Landrein N; Dacheux D; Courtois P; Lauruol F; Daulouède S; Vincendeau P; Robinson DR
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005125. PubMed ID: 27855164
[TBL] [Abstract][Full Text] [Related]
12. Functional and structural analysis of AT-specific minor groove binders that disrupt DNA-protein interactions and cause disintegration of the Trypanosoma brucei kinetoplast.
Millan CR; Acosta-Reyes FJ; Lagartera L; Ebiloma GU; Lemgruber L; Nué Martínez JJ; Saperas N; Dardonville C; de Koning HP; Campos JL
Nucleic Acids Res; 2017 Aug; 45(14):8378-8391. PubMed ID: 28637278
[TBL] [Abstract][Full Text] [Related]
13. The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain.
Sanderson L; Dogruel M; Rodgers J; Bradley B; Thomas SA
J Neurochem; 2008 Nov; 107(4):1136-46. PubMed ID: 18823367
[TBL] [Abstract][Full Text] [Related]
14. Trypanocidal activity of dicationic compounds related to pentamidine.
Donkor IO; Assefa H; Rattendi D; Lane S; Vargas M; Goldberg B; Bacchi C
Eur J Med Chem; 2001 Jun; 36(6):531-8. PubMed ID: 11525843
[TBL] [Abstract][Full Text] [Related]
15. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness.
Wenzler T; Yang S; Patrick DA; Braissant O; Ismail MA; Tidwell RR; Boykin DW; Wang MZ; Brun R
Antimicrob Agents Chemother; 2014 Aug; 58(8):4452-63. PubMed ID: 24867978
[TBL] [Abstract][Full Text] [Related]
17. Indole and Benzimidazole Bichalcophenes: Synthesis, DNA Binding and Antiparasitic Activity.
Farahat AA; Ismail MA; Kumar A; Wenzler T; Brun R; Paul A; Wilson WD; Boykin DW
Eur J Med Chem; 2018 Jan; 143():1590-1596. PubMed ID: 29126729
[TBL] [Abstract][Full Text] [Related]
18. Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis.
Barker RH; Liu H; Hirth B; Celatka CA; Fitzpatrick R; Xiang Y; Willert EK; Phillips MA; Kaiser M; Bacchi CJ; Rodriguez A; Yarlett N; Klinger JD; Sybertz E
Antimicrob Agents Chemother; 2009 May; 53(5):2052-8. PubMed ID: 19289530
[TBL] [Abstract][Full Text] [Related]
19. Activity of diimidazoline amides against African trypanosomiasis.
Dong Y; Wang X; Cal M; Kaiser M; Vennerstrom JL
Bioorg Med Chem Lett; 2014 Feb; 24(3):944-8. PubMed ID: 24398295
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
Nwodo NJ; Brun R; Osadebe PO
J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]